Harrow (HROW) EBT (2010 - 2026)
Harrow (HROW) posted EBT of -$17.3 million for Q2 2026, up 37.38% on a QoQ basis from -$27.6 million in Q1 2026, and down 445.75% year-over-year from $5.0 million in Q2 2025.
Analysis
Harrow (HROW) EBT (2010 - 2026) Analysis & Trends
Harrow has reported EBT for 17 years, with the latest figure at -$17.3 million in Q2 2026.
- On a quarterly basis, EBT fell 445.75% year-over-year to -$17.3 million in Q2 2026; TTM through Jun 2026 was -$33.4 million, a 211.79% decrease from a year earlier, with the FY2025 full-year figure at -$1.4 million, up 92.1% from the prior year.
- EBT was -$17.3 million for Q2 2026 at Harrow, up from -$27.6 million in the prior quarter.
- The five-year high for EBT was $10.4 million in Q4 2025, with the low at -$27.6 million in Q1 2026.
- Average EBT over 5 years is -$5.6 million, with a median of -$5.0 million recorded in 2023.
- The sharpest annual moves came in 2022 and 2025: EBT tumbled 1223.5% in 2022, then surged 185.85% in 2025.
- Over 5 years, EBT stood at $1.1 million in 2022, then slumped by 1017.82% to -$9.7 million in 2023, then jumped by 164.68% to $6.3 million in 2024, then surged by 66.01% to $10.4 million in 2025, then plunged by 266.11% to -$17.3 million in 2026.
- The last three EBT figures came in at -$17.3 million (Q2 2026), -$27.6 million (Q1 2026), and $10.4 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 642.70 Bn | 621.95 Bn | 17.26 Bn | 6.75 Bn |
| 2 | AbbVie | 440.80 Bn | 434.23 Bn | 12.70 Bn | 4.28 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | -683.00 Mn |
| 4 | Novartis Ag | 266.37 Bn | 258.68 Bn | 11.24 Bn | 4.27 Bn |
| 5 | Pfizer | 158.89 Bn | 147.19 Bn | 10.94 Bn | -653.00 Mn |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn | 1.64 Bn |
| 7 | Revolution Medicines | 44.38 Bn | 44.38 Bn | - | -644.37 Mn |
| 8 | Incyte | 25.28 Bn | 20.74 Bn | 1.57 Bn | 751.51 Mn |
| 9 | United Therapeutics | 21.46 Bn | 18.80 Bn | 683.80 Mn | 372.70 Mn |
| 10 | Harrow | 1.41 Bn | 1.32 Bn | 50.36 Mn | -17.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -17.27 Mn |
| Mar 31, 2026 | -27.58 Mn |
| Dec 31, 2025 | 10.40 Mn |
| Sep 30, 2025 | 1.02 Mn |
| Jun 30, 2025 | 5.00 Mn |
| Mar 31, 2025 | -17.78 Mn |
| Dec 31, 2024 | 6.26 Mn |
| Sep 30, 2024 | -4.20 Mn |
| Jun 30, 2024 | -5.82 Mn |
| Mar 31, 2024 | -13.57 Mn |
| Dec 31, 2023 | -9.68 Mn |
| Sep 30, 2023 | -2.85 Mn |
| Jun 30, 2023 | -4.24 Mn |
| Mar 31, 2023 | -6.93 Mn |
| Dec 31, 2022 | 1.06 Mn |
| Sep 30, 2022 | -6.43 Mn |
| Jun 30, 2022 | -6.20 Mn |
| Mar 31, 2022 | -2.44 Mn |
| Dec 31, 2021 | -7.29 Mn |
| Sep 30, 2021 | -8.33 Mn |